Pathway View: What's Driving This?
A simple biology story for each case: which pathways look most involved, and how that ties to therapy (researchāmode).
Pathway View: What's Driving This?
In-silico means "in silicon" - referring to computer-based analysis that simulates and predicts biological processes.
A simple biology story for each case: which pathways look most involved, and how that ties to therapy (researchāmode).
Observed Outcomes
Real-world transformation stories showing how our platform revolutionizes research workflows and decision-making
Stable Pathway Rankings
Topā3 pathways stabilize across reāruns with fewer rank flips, providing reliable biological insights for clinical decision-making.
Reduced Discussion Time
Clear therapy alignment hints reduce board discussion time and guide WIWFM inputs, streamlining clinical workflows.
Confidence Improvement
Confidence improves when supportive chips and cohort overlays are present, enhancing decision-making reliability.
Evidence Tier Promotions
Evidence tier promotions occur when pathways and priors/literature align, strengthening research foundations.
Standardized Review
Shareable oneāpager with run ID/profile standardizes review processes and ensures complete provenance tracking.
Research Use Only
All metrics represent validated performance in research environments. Results may vary based on specific use cases and data quality.
Core Capabilities
3 advanced AI-powered capabilities designed to transform your workflow
Biology Summary Card (live)
Capability Deep Dive
Technical Approach
Advanced AI-powered capabilities
Pathway Mapping Engine
Maps variants to pathways using transparent weights and gene burden calculations
Contribution Visualization
Displays top 3 pathways with contribution bars and one-line explanations
Provenance Tracking
Includes run ID and profile on every card for complete auditability
The Value Proposition Flywheel
Strategic advantages that create a self-sustaining cycle of value delivery for each target audience.
For the Clinician
- A quick biology story tied to therapy choices.
- Short, shareable text with sources (RUO).
- Consistent format across cases.
For the Research Team
- Transparent mapping and weights.
- Provenance for QA and reuse.
- Optional cohort overlay to strengthen the case.
This value delivery cycle creates a self-sustaining loop of strategic advantages, accelerating therapeutic development and market adoption at an unprecedented pace.
Strategic Conclusion
Explore Other Co-Pilots
Chemo CoāPilot: InāSilico Chemotherapy Guidance
Ināsilico chemotherapy insight: see which drug classes may fit a patient's geneticsābefore you treat. Clear signals, confidence, and sources (researchāmode).
CRISPR Intelligence: Advanced Therapeutic R&D Platform
An advanced R&D platform for designing, predicting, and validating CRISPR-based therapeutics with unparalleled precision and speed.
Clinical Trials CoāPilot: InāSilico Trial Matching
Find matching trials in minutes. Clear eligibility and a shareable oneāpager (researchāmode).
Therapy Fit: InāSilico Drug Ranking
See which drug classes may fit a patient's geneticsābefore treatment. Clear ranking, confidence, and sources (researchāmode).
Toxicity Risk (Germline): InāSilico SideāEffect Hints
See simple, geneticsāaware sideāeffect hints to plan conservativelyābefore treatment (researchāmode).